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Case Presentations

A Case Of Chronic Intestinal Pseudo-Obstruction
Matt Baichi, MD, Resident, Internal Medicine 2000-2003

Introduction
Scleroderma is a systemic disease characterized by the
deposition of excessive collagen and other matrix
elements in the skin as well as in multiple internal organs.
Scleroderma can be classified into diffuse cutaneous
disease and limited cutaneous disease1. Limited
cutaneous disease is characterized by skin involvement
limited to the hands, face, feet, and forearms; it includes
the CREST variant (calcinosis, raynauds, esophageal
dysmotility, sclerodactyly, and telangiectasia). Diffuse
cutaneous disease is characterized by skin involvement as
well as early and diffuse visceral involvement. Clinically
significant gastrointestinal involvement occurs in
approximately 50% of all patients with scleroderma2. The
esophagus is the most common site of involvement
followed by the ano-rectum, small bowel, colon, and
stomach. Several recent reviews of the gastrointestinal
manifestations of scleroderma have been written3-5. Here,
a case of diffuse gastrointestinal scleroderma presenting
as chronic intestinal pseudo-obstruction is described.
Case report
The patient is a 52-year-old female with a 30-year history
of GERD, 10-year history of chronic constipation, and a
questionable 4-year history of Crohn’s disease. The
patient was in her usual state of health until three months
prior to this admission. At that time, she was hospitalized
for nausea and vomiting. Work-up revealed a nonmechanical small bowel obstruction that resolved with
conservative management. She was re-hospitalized six
times for similar complaints. Each admission revealed
non-mechanical small bowel obstruction. Her last
admission, however, revealed an ileal stricture, which was
subsequently removed. The patient now presents to our
hospital with complaints of nausea, bilious emesis,
bloating, abdominal distention, increased belching, and
decreased appetite. She denies dysphagia, abdominal
pain, melena, hematochezia, or diarrhea. She denies
history of hepatitis, pancreatitis, or gallbladder disease.
Since her first hospitalization three months ago, she has
lost 25 pounds. Social history is remarkable for 80-pack
years of tobacco. Family history reveals no gastrointestinal disease. Review of systems is remarkable for
persistent parathesias and Raymaud's.

The patient is a moderately cachectic white female. Vital
signs are unremarkable except for mild tachycardia.
Abdominal exam reveals normal bowel sounds, marked
distention, tympanic percussion, soft and non-tender to
palpation, without guarding or rebound, and without
hernia. Rectal exam reveals external hemorrhoids with
brown stool positive for occult blood. Rheumatologic
exam reveals mildly thickened and cool fingers, no
inflamed joints, normal skin. Neurologic exam reveals
normal muscle tone and strength. Blood count is
remarkable for white count 14600/mL with normal
differential. Chemistry profile is remarkable for
potassium 2.5 Meq/L. Liver profile, amylase, and lipase
were within normal limits. ESR 17 seconds, ANA 1:40,
speckled. Anticentromere Ab and Anti Scl 70 Ab were
negative. Obstruction series showed multiple dilated
small bowel loops with relative collapse of the large
bowel, air fluid levels within the small bowel, and no
intra-peritoneal free air. Pathology of the resected
terminal ileum(from previous hospitalization) revealed
patchy marked atrophy and fibrosis of the muscularis
propria with preferential involvement of the circular
layer, vacuolar degeneration of muscle fibers were
present, without inflammatory changes of Crohn’s
Disease. Esophageal manometry revealed lower
esophageal sphincter resting pressure in the lower range
of normal with aperistalsis of the esophageal body. Small
bowel radiographs revealed moderate mega-duodenum
with “hide-bound” configuration of mucosal folds
throughout the small intestine, but no stricture. Upper
endoscopy revealed erosive esophagitis and moderate
hiatal hernia. Colonoscopy revealed neoileo-colonic
anastamosis that was friable and ulcerated. Biopsy of the
anastamosis showed granulation tissue and lamina
propria compatible with the anastamotic site.
Diagnosis
Our patient presented with chronic intestinal pseudoobstruction6-9. This is a rare condition characterized by
recurrent episodes of intestinal obstruction in the absence
of any mechanical defect. Symptoms include nausea,
vomiting, abdominal distention, bloating, abdominal
pain, and constipation. The differential diagnosis can be
divided into myopathic vs neuropathic disorders.
Myopathic conditions include infiltrative processes such
(Continued on next page)
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as scleroderma and amyloidosis, familial conditions such
as visceral myopathies, and neurologic conditions such
as myotonic and other dystrophies. In this case, the
history is significant for esophageal dysmotility
(longstanding GERD) and Raynaud’s phenomenon.
Recent ileal biopsy shows patchy atrophy and fibrosis of
the muscularis with preferential involvement of the
circular layer. These findings are consistent with
scleroderma. Histologically, the most significant changes
occur in the muscularis layer of bowel. Atrophy and
fragmentation of smooth muscle occurs. Initially the
atrophy is patchy and later becomes more extensive with
associated fibrosis10,11. These changes are more
pronounced in the circular smooth muscle layer12, and
atrophy usually exceeds fibrosis13. Subsequent small
bowel imaging and esophageal manometry confirmed
the diagnosis (see discussion).
Discussion
The esophagus is the most commonly affected organ in
the gastrointestinal tract. Normal esophageal manometry
shows high amplitude, ordered peristaltic waves and a
high resting pressure of the lower esophageal sphincter
(LES). On swallowing, the LES relaxes to baseline, and
the LES relaxation precedes the arrival of the peristaltic
wave. Manometry studies in early scleroderma show
increased velocity of the peristaltic wave, discordance of
the peristaltic wave with LES relaxation, and failure of
the LES to relax to baseline. Later findings include
decreased amplitude of peristalsis and low LES resting
pressure progressing to aperistalsis in the smooth muscle
portion of the esophagus with absent LES resting
pressure14,15. Gastroesophageal reflux disease (GERD) is
the most significant clinical condition. GERD occurs as
a result of both the decreased LES resting pressure, which
allows an increased number of reflux events, and poor
peristalsis, which delays acid clearance16,17. The
complications of longstanding GERD include candida
esophagitis, erosive esophagitis, esophageal stricture,
Barret’s esophagus, and aspiration. Diagnostic evaluation
should therefore include upper endoscopy to rule out
complications.

The small intestine is also commonly involved. In the
normal small bowel, a cyclical pattern of contractile
activity occurs at regular intervals. This is called the
migrating myoelectric complex (MMC). The MMC acts
as an “intestinal housekeeper” by clearing remnants of
digestion and preventing bacterial overgrowth18. Patients
with scleroderma often lack this MMC. Clinically,
chronic intestinal pseudoobstruction and malabsorbtion
are seen. Malabsorbtion is the result of bacterial
overgrowth19. The H2 breath test is a noninvasive and
reliable diagnostic procedure. A nonabsorbable
carbohydrate such as lactulose is ingested and a
premature rise in exhaled H2 suggests the presence of
intestinal bacteria. The diagnosis of chronic intestinal
pseudoobstruction from scleroderma can be made with
small bowel barium imaging or biopsy20,21. A “hidebound” configuration of the small bowel is a characteristic mucosal fold pattern in which there is a relative
decrease in the distance separating the valvulae
conniventes. This creates an accordion-like appearance.
This finding is uniquely associated with scleroderma.
Less common intestinal presentations include
pneumatosis cystoides intestinalis, small intestineal
telangiectasia, and small bowel diverticula. Prokinetic
drugs such as metaclopramide, erythromycin, and
octreotide are the treatments of choice.
In the colon, the ano-rectum is commonly affected.
Manometry reveals an absent or diminished rectoanal
inhibitory reflex22. Also, colonic transit is prolonged23
and the normal postprandial increase in rectosigmoid
motility is lost24. Clinically, fecal incontinence and
constipation are the most common presentations. Less
common presentations include diarrhea, rectal prolapse,
spontaneous perforation, and colonic infarction.
Radiographic evaluation of colonic involvement
includes barium enema, which may show characteristic
“wide mouth”, or “fish mouth” diverticula, which are
broad based true diverticula caused by the uneven
distribution of atrophic muscularis20. Treatment includes
conservative measures such as increased fluid and fiber
intake. Prokinetic agents can be used for improved
colonic inertia.
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